Pediococcus acidilactici derived antimicrobial hexapeptide and preparation method thereof
10487112 · 2019-11-26
Assignee
Inventors
Cpc classification
A01N63/20
HUMAN NECESSITIES
B01D15/34
PERFORMING OPERATIONS; TRANSPORTING
A01N63/20
HUMAN NECESSITIES
Y02A50/30
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
A23C9/1526
HUMAN NECESSITIES
A01N37/18
HUMAN NECESSITIES
A23K20/147
HUMAN NECESSITIES
International classification
B01D15/34
PERFORMING OPERATIONS; TRANSPORTING
B01D61/14
PERFORMING OPERATIONS; TRANSPORTING
B01D15/36
PERFORMING OPERATIONS; TRANSPORTING
A01N37/18
HUMAN NECESSITIES
C07K7/00
CHEMISTRY; METALLURGY
Abstract
A Pediococcus acidilactici derived antimicrobial hexapeptide and a preparation method thereof are disclosed herein. The antimicrobial peptide ENGEEE (SEQ ID NO: 1) is reported for the first time. Antimicrobial peptide lactein R16 has good pH stability and thermal stability, has an effect on inhibiting Escherichia coli, Listeria monocytogenes and Staphylococcus aureus and is capable of effectively reducing the amount of the Escherichia coli in soybean meal. Secondly, the antimicrobial peptide lactein R16 has a certain effect on proliferating Saccharomyces cerevisiae and Lactobacillus plantarum and has certain capability of clearing hydrogen peroxide, hydroxyl radicals, DPPH radicals and superoxide anions. The antimicrobial peptide lactein R16 can be used for biological control and can be used as a feed additive to play important roles in substituting antibiotics and solving the feed safety problem.
Claims
1. A composition comprising an antimicrobial peptide consisting of the amino acid sequence of SEQ ID NO: 1, and a soybean meal.
2. The composition of claim 1, further comprising Escherichia coli.
3. A method of inhibiting bacterial infection in a subject, comprising administering the composition of claim 1 to the subject in need thereof.
4. The method of claim 3, wherein the bacterial infection is selected from the group consisting of Escherichia coli, Listeria monocytogenes and Staphylococcus aureus.
Description
BRIEF DESCRIPTION OF FIGURES
(1)
(2)
(3)
(4)
(5)
DETAILED DESCRIPTION
(6) Formulae of various buffer solutions in the invention can be found in a laboratory manual.
Embodiment 1: Preparation of Lactein R16
(7) Antimicrobial hexapeptide lactein R16 is prepared by using the following method:
(8) 1. fermenting Pediococcus acidilactici to obtain the antimicrobial hexapeptide, and after centrifuging a fermented supernatant, collecting the supernatant, and carrying out ultrafiltration (the molecular weight cut-off is 3000 Da) and concentration to realize 8-10 times concentration to obtain a crude extract;
(9) 2. carrying out separation by using an anion exchange chromatography Hitrap Q FF: loading a sample of the crude extract on an Hitrap Q FF chromatographic column to carry out separation to obtain two eluting peaks, collecting an active peak having an antimicrobial effect for Escherichia coli, and carrying out freeze drying after sufficiently dialyzing the collected active peak L2 by using Mill-Q water;
(10) 3. carrying out separation by using a gel filtration chromatography Superdux Peptide 10/300GL: loading a sample of the eluting peak L2 of the anion exchange chromatography on a Superdux Peptide 10/300GL gel filtration chromatographic column to carry out separation to obtain two eluting peaks, collecting an active peak having an antimicrobial effect for Escherichia coli, and carrying out freeze drying after sufficiently dialyzing the collected active peak N2 by using Mill-Q water;
(11) 4. carrying out separation by using a reversed-phase C.sub.18 column: dissolving the sample subjected to freeze drying in the previous step by using 5% acetonitrile (containing 0.1% TFA, the same below), eluting the sample by using 5-50% linear gradient increasing acetonitrile by a 5% acetonitrile-balanced C.sub.18 column, collecting an active eluting peak H3, and carrying out rotary evaporation and freeze drying to obtain a final product; and
(12) 5. carrying out identification by using an LC-MS: after dissolving the sample having the antimicrobial activity and being subjected to freeze drying in the previous step by using Mill-Q water, and carrying out identification by using the LC-MS, wherein the flowing phases are A (the ratio of acetonitrile to water to formic acid is equal to 30:970:1 (V:V:V)) and B (the ratio of acetonitrile to water to formic acid is equal to 700:300:1 (V:V:V)); the eluting program lasts for 0-10 min and adopts 100% A and 0% B, or lasts for 20 min and adopts 70% A and 30% B, or lasts for 30 min and adopts 0% A and 100% B, or lasts for 35 min and adopts 100% A and 0% B; the flow rate is 1 mL/min; and the column temperature is 30 C. The mass spectrum conditions are as follows: the voltage of a capillary tube is 3.88 kV, the voltage of a cone is 20 V, the temperature of an ion source is 120 C., the desolvation temperature is 300 C., the flow rate is 1 mL/min, and the split ratio is 50:1; and analyzing a result by using software MassLynx4.1.
(13) Identified by using a mass spectrum, the antimicrobial peptide has the molecular weight of 705.17 Da and the amino acid sequence of E-N-G-E-E-E (shown as SEQ ID NO. 1).
(14) Compared with a database such as an antimicrobial peptide database, the antimicrobial peptide is not reported.
Embodiment 2: Biological Characteristics of Lactein R16
(15) Stability of Lactein R16 in pH
(16) 10 parts of purified active substance lactein R16 with the concentration of 100 mg.Math.mL.sup.1 is selected, the pH of the lactein R16 is respectively regulated to be 1.0-10.0 by using 1.0 mol.Math.L.sup.1 NaOH and 1.0 mol.Math.L.sup.1 HCl, the lactein R16 is treated in a 37 C. water bath kettle for 2 h, then, the pH of the lactein R16 is regulated to be 4.5, and an antimicrobial experiment is performed to observe the inhibition of the lactein R16 to Escherichia coli. The result is shown as
(17)
(18) Thermal Stability of Lactein R16
(19) 8 parts of purified active substance lactein R16 with the concentration of 100 mg.Math.mL.sup.1 is selected and is respectively treated at 40 C., 50 C., 60 C., 70 C., 80 C., 90 C. and 100 C. for 30 min and is subjected to high-pressure sterilization at 121 C. for 15 min, and an antimicrobial experiment is performed to observe the inhibition of the lactein R16 to Escherichia coli. The result is shown as
(20) It can be know from
(21) Antimicrobial Spectrum of Lactein R16
(22) 8 parts of purified active substance lactein R16 with the concentration of 100 mg.Math.mL.sup.1 is selected, and an inhibiting effect of the lactein R16 on Escherichia coli, Listeria monocytogenes and Staphylococcus aureus is detected by using an oxford-cup method.
(23) Pathogenic microorganisms such as Escherichia coli and Listeria monocytogenes are easily carried in the transportation and storage processes of a feed and can enter bodies of animals along with the feed to induce intestinal infectious diseases of the animals and seriously threaten the health of the animals. The inhibiting effect of the lactein R16 on common pathogenic bacteria of the animals is shown as table 1.
(24) TABLE-US-00001 TABLE 1 Antimicrobial Spectrum of Lactein R16 Bacteria Antimicrobial level Escherichia coli K99 ++ Escherichia coli JM109 ++ Escherichia coli ATCC 25922 + Listeria monocytogenes CMCC(B)54002 ++ Staphylococcus aureus ATCC 6538 +++ Note: +++ represents for strong inhibition, ++ represents for relatively strong inhibition, + represents for inhibition, and represents for no inhibition.
(25) It can be known from table 1 that the lactein R16 shows relatively strong antimicrobial activity for Staphylococcus aureus, Escherichia coli K99, Escherichia coli J M109 and Listeria monocytogenes, wherein the antimicrobial effect for Staphylococcus aureus is strongest.
(26) Minimum Inhibitory Concentration of Lactein R16
(27) The antimicrobial activity is detected by adopting a minimum inhibitory concentration (MIC) method, and the operation is as follows:
(28) (a) inoculating the bacteria into an LB liquid culture medium according to the inoculation amount of 1%, and carrying out shaking culture over the night at 37 C. and 200r.Math.min.sup.1;
(29) (b) inoculating the culture solution into 20 mL of the LB liquid culture medium according to the inoculation amount of 1%, and carrying out shaking culture at 37 C. and 200r.Math.min until the OD.sub.600 is equal to about 0.5;
(30) (c) inoculating a bacterial suspension of which the OD.sub.600 is equal to 0.5 into 10 mL of the LB liquid culture medium according to the inoculation amount of 0.01%, and carrying out vibration and uniform shaking to control the bacterial density at 1*10.sup.5-5*10.sup.5 CFU.Math.mL.sup.1, and measuring the MIC;
(31) (d) carrying out gradient dilution on antimicrobial active substances to ensure that the final concentrations of the antimicrobial active substances are 256, 128, 64, 32, 16, 8, 4, 2 and 1 mg.Math.mL.sup.1;
(32) (e) adding 450 L of the prepared bacterial suspension into an aseptic tissue culture plate, and then, respectively adding 50 L of antimicrobial active substance diluents with corresponding concentrations to ensure that the concentrations of to-be-measured antimicrobial active substances are respectively 25.6, 12.8, 6.4, 3.2, 1.6, 0.8, 0.4, 0.2 and 0.1 mg.Math.mL.sup.1; and carrying out culture in a 37 C. constant-temperature incubator for 18-24 h by taking 500 L of the bacterial suspension as a positive control and 500 L of the LB liquid culture medium as a negative control; and
(33) (f) observing whether bacteria are precipitated at the bottom of each hole or not, and determining that the minimum concentration at which no precipitated bacteria are visible to naked eyes is the MIC of the antimicrobial active substances.
(34) The MICS of the lactein R16 to Escherichia coli, Listeria monocytogenes and Staphylococcus aureus are shown as table 2 from which it can be known that the MICS of the antimicrobial active substances to Escherichia coli and Listeria monocytogenes are 6.4 mg.Math.mL.sup.1, and the MICs of the antimicrobial active substances to Staphylococcus aureus are 3.2 mg.Math.mL.sup.1.
(35) TABLE-US-00002 TABLE 2 MICs of Lactein R16 to Bacteria Bacteria MIC/mg .Math. mL.sup.1 Escherichia coli K99 6.4 Staphylococcus aureus ATCC 6538 3.2 Listeria monocytogenes CMCC(B)54002 6.4
(36) Influences of Lactein R16 on Probiotics
(37) Each of probiotics is subjected to two-stage activation, is inoculated into an MRS culture medium containing 6.4 mg.Math.mL.sup.1 of antimicrobial active substances according to the inoculation amount of 1% and is cultured at the constant temperature of 37 C. for 24 h in contrast with the probiotics inoculated into the MRS culture medium. Coated plate counting is performed by using a viable count method. The result is shown as
(38) A microecological preparation used as one of green feed additives is widely applied to the feed, wherein a composite microecological preparation prepared from Saccharomycetes, Lactic Acid Bacteria and Bacillus is more common, not only can degrade and soften crude fibers and increase the content of proteins, but also can improve the palatability of the feed, regulate the intestinal microecological balance of the animals and promote digestive absorption and growth. Saccharomyces cerevisiae, Pediococcus pentosaceus, Enterococcus faecium, Lactobacillus plantarum and Bacillus subtilis are selected as a study object to study the influences of the lactein R16 on Saccharomyces cerevisiae, Pediococcus pentosaceus, Enterococcus faecium, Lactobacillus plantarum and Bacillus subtilis, and the result is shown as
(39) It can be known from
(40) Antioxidant Capability of Lactein R16
(41) The feed contains a certain quantity of unsaturated fat, fatty acid, lipid-soluble vitamin, carotenoid and other lipid-soluble substances, which are easily oxidized in a storage process of the feed, and particularly fat and fatty acid can be oxidized to result in rancidity to generate different compounds such as aldehyde, alcohol, fat and acid which may generate various peculiar smells to seriously affect the palatability of the feed, and some compounds can generate adverse effects for the animals due to certain toxicity. The antioxidant capability of the lactein R16 to hydrogen peroxide, hydroxyl radicals, DPPH.radicals and superoxide anions is shown as
(42) It can be know from
Embodiment 3: Application of Lactein R16
(43) Application Method:
(44) (a) crushing soybean meal by using a blade crusher, adding 4 parts (the weight of each part is 40 g) of soybean meal with the serial numbers of group 5, group 6, group 7 and group 8 into a 500 mL fermentation flask, and carrying out sterilization at 105 C. for 10 min;
(45) (b) carrying out fermentation under conditions shown as table 3.
(46) TABLE-US-00003 TABLE 3 Initial Fermentation Conditions of Soybean Meal Containing Lactein R16 Parameter level Fermentation Conditions contrast group 3 contrast group 4 sample loading volume/g 40 40 40 40 Addition amount/g of antimicrobial 0 0.512 0 0.512 active substances Inoculation amount/mL of 1 1 1 1 Escherichia coli with the concentration of 10.sup.3 CFU .Math. mL.sup.1 Material-to-liquid ratio 1:0.8 1:0.8 1:0.12 1:0.12 Fermentation temperature/ C. 37 37 37 37 Fermentation time/h 48 48 48 48
(47) (c) measuring the amount of Escherichia coli according to the natural standard for measuring Escherichia coli in the feed.
(48) The inhibiting effect of the lactein R16 to Escherichia coli in the soybean meal is studied by adding Escherichia coli into the sterilized soybean meal. The result shows that the amount of Escherichia coli is increased from 1380.Math.100 g.sup.1 before fermentation to 4*10.sup.6.Math.100 g.sup.1 after fermentation when the lactein R16 is not added, and the amount of Escherichia coli is increased from 1380.Math.100 g.sup.1 before fermentation to 123.Math.100 g.sup.1 after the lactein R16 is added, which proves that the lactein R16 can be used for greatly removing Escherichia coli in the soybean meal while effectively reducing the amount of Escherichia coli, and the removal rate reaches 33.44%.
(49) In consideration of a certain difference between industrial soybean meal fermentation realized by using lactic acid bacteria and laboratory fermentation, on the basis of original experiment, a soybean meal fermentation experiment is performed by changing the material-water ratio of 1:0.8 into 1:0.12 and keeping other experiment conditions unchanged, and the result shows that the removal rate of the lactein R16 to Escherichia coli in the soybean meal is increased from 33.44% to 56.64%, which proves that the lactein R16 can sufficiently act on Escherichia coli under an industrial condition.
Embodiment 4: Application of Lactein R16
(50) As the unique bacteriocin allowed to be used in food preservation at present, the lactein can be added into foods such as milk and meat products to inhibit the growth of contaminating bacteria and prolong the shelf life.